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Abstract: Androgen receptor (AR) targeting remains the gold standard treatment for advanced
prostate cancer (PCa); however, treatment resistance remains a major clinical problem. To study
the therapeutic effects of clinically used anti-androgens we characterized herein a tissue-mimetic
three-dimensional (3D) in vitro model whereby PCa cells were cultured alone or with PCa-associated
fibroblasts (CAFs). Notably, the ratio of PCa cells to CAFs significantly increased in time in favor
of the tumor cells within the spheroids strongly mimicking PCa in vivo. Despite this loss of CAFs,
the stromal cells, which were not sensitive to androgen and even stimulated by the anti-androgens,
significantly influenced the sensitivity of PCa cells to androgen and to the anti-androgens bicalutamide
and enzalutamide. In particular, DuCaP cells lost sensitivity to enzalutamide when co-cultured with
CAFs. In LAPC4/CAF and LNCaP/CAF co-culture spheroids the impact of the CAFs was less
pronounced. In addition, 3D spheroids exhibited a significant increase in E-cadherin and substantial
expression of vimentin in co-culture spheroids, whereas AR levels remained unchanged or even
decreased. In LNCaP/CAF spheroids we further found increased Akt signaling that could be
inhibited by the phosphatidyl-inositol 3 kinase (PI3K) inhibitor LY294002, thereby overcoming the
anti-androgen resistance of the spheroids. Our data show that CAFs influence drug response of
PCa cells with varying impact and further suggest this spheroid model is a valuable in vitro drug
testing tool.
Keywords: prostate cancer; three-dimensional epithelial–stromal spheroids; cancer-associated
fibroblasts; anti-androgens; E-cadherin; Akt signaling
1. Introduction
Prostate cancer (PCa) is the most common male cancer in Western societies [1]. Whereas
patients with locally confined PCa are usually treated by surgical removal of the prostate or radiation,
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androgen deprivation therapy (ADT) via chemical castration has become the gold standard treatment
for advanced tumors (reviewed by [2]). Despite good initial response to ADT, most patients
invariably recur with castration-resistant prostate cancer (CRPC) [3]. It is well accepted that the
androgen receptor (AR) is a major driver of CRPC, rendering the AR a potential anti-cancer target [4].
A number of next-generation AR targeting drugs such as enzalutamide and abiraterone have been
developed [5–8]. However, despite a survival benefit in men taking these novel anti-androgens [9],
resistance mechanisms frequently occur and inevitably drive disease progression [9–12].
Our current knowledge regarding the mechanisms of anti-androgen resistance in PCa mostly
derives from in vitro studies using AR-positive PCa cell lines such as LNCaP, LAPC4, and DuCaP.
However, cells grown in standard 2D monolayer culture have a high replicative capacity and therefore
different growth characteristics and metabolic features compared to human prostate tissue [13,14],
which may account for their poor predictive value of drug response. To overcome these limitations,
three-dimensional (3D) culture models are increasingly being used as they are thought to better reflect
the properties of human tissue. However, a number of different 3D models employ extracellular matrix
(ECM) or other scaffolds that significantly influence cell biology and growth, rendering interpretation
and comparison of data rather problematic. Moreover, cancer cells are strongly influenced by the
surrounding stroma, which not only modulates local tumor spreading and progression but also
has a significant impact on therapy resistance (recently reviewed by [15]). Despite this knowledge,
few studies have combined 3D co-culture of stromal and PCa cells. Thus, a detailed characterization of
3D PCa models should be undertaken for reliable interpretation of results particularly regarding drug
effects and their translation to the in vivo situation. This study aimed to characterize the usefulness of
3D cultured PCa/CAF co-culture spheroids to investigate the effects of clinically used anti-androgens.
2. Results
2.1. Growth Characteristics of LNCaP, DuCaP, and LAPC4 3D Spheroids in the Absence or Presence of
Cancer-Associated Fibroblasts (CAFs)
When cultured alone, all three PCa cell lines produced monoculture spheroids of different forms
and sizes within 4–6 days. As depicted in Figure 1A, LNCaP cells produced irregular stellate spheroids
with a mean radius of 594.3 ± 38.1 µm by day 8 with a moderate increase in size compared to day 4
(p > 0.05, Figure 1B). LAPC4 spheroids were round but compact with a mean radius of 416.8 ± 5.7 µm
within eight days of culture. DuCaP cells formed compact irregular-shaped spheroids with a mean
radius of 462.3 ± 14.9 µm by day 8. Notably, the formation of DuCaP spheroids was temporally
delayed compared to the other cell lines. DuCaP cells formed micro-aggregates by day 4, which
associated to a larger compact spheroid at day 6. Both LAPC4 and DuCaP spheroids significantly
increased in size over time (Figure 1B, p < 0.05). CAFs cultured under 3D conditions formed compact
round but very small spheroids by day 8 (mean radius of 168.4 ± 7.4 µm). Moreover, CAF spheroids
did not increase in size over time but shrunk significantly instead (p < 0.001). Notably, however,
cell viability with respect to the mitochondrial metabolic activity of CAFs and LNCaP, as assessed by
WST-1 assay at day 4 of culture (Figure 1C), was significantly reduced in 3D spheroids compared to 2D
monolayers. In DuCaP cells, on the other hand, 3D spheroids and 2D cultures did not significantly
differ with respect to cell viability. In this cell line, absorbance values were much lower than those of
LNCaP and CAF, suggesting that these cells have a lower basal metabolic activity.
We next investigated whether there are differences in population doublings (PDL) between 2D
and 3D culture (Table 1). While the PDL values of LNCaP cells were lower in 3D spheroids compared
to the 2D culture after four days, they reached similar levels after eight days of culture, indicating
that the tumor cells need some time to adapt to 3D growth conditions. Consistent with the decreasing
size of CAF 3D spheroids over time (Figure 1B), PDL calculations indicate that the number of CAFs
decreased in 3D culture (Table 1).
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were taken at the day indicated (magnification 10×, scale bar: 500 μm); (B) mean radius of the 
spheroids was calculated at day 4 and day 8 as described in Materials and Methods. Error bars denote 
SEM. Statistical significance is shown; (C) Cell viability of 2D monolayer cultures and 3D spheroids 
was assessed by WST-1 assay, as described in Materials and Methods. Mean absorbance plus SEM 
was normalized to cell number. * p < 0.05; *** p < 0.001. 
Table 1. Population doublings (PDL) of LNCaP and CAF in 2D and 3D culture. 
Cell Line PDL Day 4 PDL Day 8
LNCaP 2D 1.000 1.459 
LNCaP 3D 0.000 1.437 
CAF 2D 2.644 3.833 
CAF 3D −2.171 −3.585 
We next investigated the characteristics of epithelial-stromal co-cultured 3D spheroids. 
LNCaP/CAF and DuCaP/CAF co-culture spheroids were significantly smaller than monoculture 
spheroids established from either 7500 or 3800 PCa cells with a mean radius of 485.7 μm 
Figure 1. Morphology and size of monoculture spheroids established from prostate cancer (PCa)
epithelial cells and PCa-associated fibroblasts (CAFs). LNCaP, LAPC4, DuCaP and CAFs were grown
in scaffold-free 96-well hanging drop plates over eight days. (A) Representative bright-field images
were taken at the day indicated (magnification 10×, scale bar: 500 µm); (B) mean radius of the spheroids
was calculated at day 4 and day 8 as described in Materials and Methods. Error bars denote SEM.
Statistical significance is shown; (C) Cell viability of 2D monolayer cultures and 3D spheroids was
assessed by WST-1 assay, as described in Materials and Methods. Mean absorbance plus SEM was
normalized to cell number. * p < 0.05; *** p < 0.001.
Table 1. Population doublings (PDL) of LNCaP and CAF in 2D and 3D culture.
ell i e PDL a 4 PDL a 8
L 2 1. 1.45
L aP 3 0.000 1.437
CAF 2D 2.644 3.833
CAF 3D −2.171 −3.585
e next investigated the characteristics of epithelial-stro al co-cultured 3 spheroids.
L CaP/CAF and uCaP/CAF co-culture spheroids were significantly s aller than onoculture
spheroids established from either 7500 or 3800 PCa cells with a mean radius of 485.7 µm (LNCaP/CAF)
and 207.3 µm (DuCaP/CAF) (Figure 2A). After four days of co-culture, GFP-labeled CAFs appeared as
small islands among the PCa cells (Figure 2B). Microscopic images revealed that the number of green
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fluorescent CAFs was reduced by day 8 compared to day 4, suggesting that the tumor cells replace the
CAFs over time. Fluorescence-activated cell sorting (FACS) of 3D co-cultured spheroids into epithelial
vs. stromal population in fact revealed that after eight days of co-culture less than 10% of the cells were
GFP positive (Figure 2C). Specifically, LNCaP/CAF contained 6.4% ± 1.7%, DuCaP/CAF 5.2% ± 2.3%
GFP-positive cells at day 8. Thus, the epithelial:stromal cell ratios were very similar between different
PCa cell lines. Notably, CAFs did not significantly lose GFP expression in 3D culture over time when
cultured in the absence of tumor cells since 70.2% ± 9.6% of the cells remained GFP-positive after eight
days (Figure 2D).
Int. J. Mol. Sci. 2016, 17, 1458 4 of 15 
 
(LNCaP/CAF) and 207.3 μm (DuCaP/CAF) (Figure 2A). After four days of co-culture, GFP-labeled 
CAFs appeared as small islands among the PCa cells (Figure 2B). Microscopic images revealed that 
the number of green fluorescent CAFs was reduced by day 8 compared to day 4, suggesting that the 
tumor cells replace the CAFs over time. Fluorescence-activated cell sorting (FACS) of 3D co-cultured 
spheroids into epithelial vs. stromal population in fact revealed that after eight days of co-culture less 
than 10% of the cells were GFP positive (Figure 2C). Specifically, LNCaP/CAF contained 6.4% ± 1.7%, 
DuCaP/CAF 5.2% ± 2.3% GFP-positive cells at day 8. Thus, the epithelial:stromal cell ratios were very 
similar between different PCa cell lines. Notably, CAFs did not significantly lose GFP expression in 
3D culture over time when cultured in the absence of tumor cells since 70.2% ± 9.6% of the cells 
remained GFP-positive after eight days (Figure 2D). 
 
Figure 2. Growth characteristics of tumor epithelial–stromal co-culture spheroids. (A) Mean radius 
was determined at day 8 of culture for spheroids established from 7500 or 3800 PCa cells per drop for 
monocultures (LNCaP, LAPC4, DuCaP) and 3800 PCa cells and 3800 CAFs for co-culture spheroids 
(LNCaP/CAF, LAPC4/CAF, DuCaP/CAF); (B) Representative fluorescence images of co-culture 
spheroids after four and eight days of culture, demonstrating GFP tracked CAFs (green) as islands 
within the spheroids (magnification 40×, scale bar: 500 μm); (C) Tumor epithelial cells (LNCaP, 
DuCaP) and GFP-labeled CAFs were separated and quantified by FACS after eight days of co-
culturing in hanging drops; (D) CAFs were grown as 3D spheroids over four and eight days and the 
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*** p < 0.001. 
2.2. E-Cadherin Protein Levels Are Increased in 3D Spheroids Compared to 2D Monolayers 
3D cell culture is likely to induce fundamental changes in cell biology due to altered cell-to-cell 
contacts, cell polarization, and differentiation. We therefore examined the expression of the luminal 
epithelial markers E-cadherin (CDH1) and cytokeratin 18 (KRT18), the stromal marker vimentin 
(VIM), the basal epithelial markers keratin 5 (KRT5) and tumor protein P63 (TP63), and the expression 
Figure 2. Growth characteristics of tumor epithelial–stromal co-culture spheroids. (A) Mean radius
was determined at day 8 of culture for spheroids established from 7500 or 3800 PCa cells per drop for
monocultures (LNCaP, LAPC4, DuCaP) and 3800 PCa cells and 3800 CAFs for co-culture spheroids
(LNCaP/CAF, LAPC4/CAF, DuCaP/CAF); (B) Representative fluorescence images of co-culture
spheroids after four and eight days of culture, demonstrating GFP tracked CAFs (green) as islands
within the spheroids (magnification 40×, scale bar: 500 µm); (C) Tumor epithelial cells (LNCaP, DuCaP)
and GFP-labeled CAFs were separated and quantified by FACS after eight days of co-culturing in
hanging drops; (D) CAFs were grown as 3D spheroids over four and eight days and the percentage of
GFP positive cells quantified by flow cytometry presented as mean plus SEM. * p < 0.05; *** p < 0.001.
2.2. E-Cadherin Protein Levels Are Increased in 3D Spheroids Compared to 2D Monolayers
3D cell culture is likely to induce fundamental changes in cell biology due to altered cell-to-cell
contacts, cell polarization, and differentiation. We therefore examined the expression of the luminal
epithelial markers E-cadherin (CDH1) and cytokeratin 18 (KRT18), the stromal marker vimentin (VIM),
the basal epithelial markers keratin 5 (KRT5) and tumor protein P63 (TP63), and the expression of
CD44 and integrin alpha 2 (ITGA2, CD49b), two cell surface glycoproteins that play an important role
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in cell adhesion and migration. When grown as 2D monolayers, the three PCa cell lines exhibited very
similar expression patterns with high levels of CDH1 and KRT18 mRNA, but moderate expression of
CD44 and ITGA2 and low to undetectable levels of VIM, KRT5, and TP63 mRNA (Figure 3A). In CAFs,
on the other hand, we found a typical stromal phenotype lacking CDH1 and KRT18 expression but
high levels of vimentin, which was, however, significantly decreased in 3D spheroids (p < 0.05). CDH1
and KRT18 mRNA expression were lower in 3D spheroids of DuCaP and LAPC4 compared to 2D
cultures (p < 0.05). In LNCaP/CAF and DuCaP/CAF co-culture spheroids, mRNA expression of the
epithelial markers CDH1 and KRT18 was further reduced compared to 3D monocultures, whereas
vimentin levels remained unchanged (Figure 3B).
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Figure 3. mRNA expression of cell type-specific markers in 3D spheroids compared to 2D monolayers.
mRNA expression of the luminal epithelial markers E-cadherin (CDH1) and cytokeratin 18 (KER18),
the stromal marker vimentin (VIM), the bas l epithelial cell markers keratin 5 (KER5) and TP63, and the
two cell surface glycoproteins CD44 and CD49b (ITGA2) in (A) 3D monoculture spheroids compared to
corresponding 2D mono ayer cultures and in (B) LNCaP/CAF and DuCaP/CAF co- lt re spheroids.
Target g ne expression was normalized to the ho s keeping genes GAPDH and HMBS nd values
expressed as relative gen expression plus SEM from at least three independent experim nts (* differe t
from 2D monolayer, p < 0.05).
We next examined the protein expression of E-cadherin and vimentin by Western blotting.
However, in contrast to mRNA expression, E-cadherin protein expression was significantly higher in
3D spheroids of all three PCa cell lines (Figure 4A) as well as in co-culture spheroids compared with
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2D cultures. Vimentin, on the other hand, was undetectable in 2D culture and 3D PCa monoculture
spheroids, but was detected at substantial levels in all co-culture spheroids, with highest expression
in DuCaP/CAF. This high expression of vimentin was somehow unexpected due to the low to
undetectable mRNA expression (Figure 3B). CAF monoculture spheroids were negative for E-cadherin
but expressed high levels of vimentin and α-smooth muscle actin (α-SMA), both of which were present
at significantly lower levels in 3D spheroids compared with 2D culture (Figure 4B). Notably, PCa cells
were positive for E-cadherin but negative for vimentin in co-culture spheroids when analyzed after
FACS separation from CAFs (Figure 4C), suggesting that vimentin expression detected in the co-culture
spheroids by Western blotting (Figure 4A) originates solely from the stromal cells.
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2.3. PCa Cells Maintain Androgen Responsiveness in 3D Culture
With regard to employing PCa spheroids as a tissue-mimetic model to study AR targeting agents,
it is important to know if these spheroids respond to androgens and whether this might be influenced
by co-culture with CAFs. To examine the androgen sensitivity of 3D spheroid cultures, we used
a treatment time of 10 days. As shown in Figure 5, LNCaP spheroids displayed reduced cell viability in
androgen-deprived medium containing 3% charcoal-stripped serum (3% CS, p > 0.05) but a significant
re-stimulation of growth upon addition of 0.1 nM R1881 (3% CS + 0.1 nM R1881; p < 0.05) (Figure 5A).
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Similarly, DuCaP spheroids showed reduced cell viability in 3% CS and were significantly re-stimulated
by 0.1 nM R1881 (p < 0.05). LAPC4 spheroids showed moderately diminished cell viability in 3% CS
compared to standard medium (mock), which routinely contains 1 nM DHT.
Co-culture spheroids also showed androgen responsiveness, albeit with varying effects in
the different cell lines (Figure 5A). The viability of LAPC4/CAF was significantly inhibited when
maintained in 3% CS (p < 0.05). LNCaP/CAF also responded with reduced cell growth in 3% CS
and was re-stimulated by 0.1 nM R1881, although the effect was less pronounced than in LNCaP
monoculture spheroids (p > 0.05). DuCaP/CAF failed to respond to androgen starvation and
a re-stimulation with R1881 could not be measured, indicating that CAFs mostly influence androgen
responsiveness of DuCaP cells. It may be noted that the CAFs employed in this study were not
androgen responsive, neither in 2D nor in 3D culture (Supplementary Materials Figure S1).
R1881 significantly upregulated expression of the androgen-regulated genes PSA and FKBP5 in
LNCaP and DuCaP monoculture spheroids (Figure 5B). Moreover, the anti-androgen enzalutamide
was able to abrogate this R1881-induced expression of PSA and FKBP5. Notably, this effect was also
seen in LNCaP and DuCaP cells following co-culture with CAFs (Figure 5C).
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Figure 5. Androgen responsiveness of PCa monoculture and PCa/CAF co-culture spheroids.
3D spheroids were cultured in androgen-deprived medium containing 3% charcoal-stripped FCS
(3% CS) with or without 0.1 nM R1881 and/or the anti-androgens bicalutamide (BIC) and enzalutamide
(ENZ) to a final concentration of 5 µM. (A) Cell viability was assessed by WST-1 assay after 10 days of
treatment and expressed as mean absorbance relative to vehicle control (mock) where spheroids were
cultured in standard medium (10% FCS + 0.1% DMSO); (B) qPCR of prostate specific antigen (PSA) and
FK506 binding protein 5 (FKBP5). Target gene expression was normalized to GAPDH and HMBS and
expressed as relative gene expression; (C) FKBP5 mRNA expression was determined in GFP negative
FACS sorted PCa cells from LNCaP/CAF and DuCaP/CAF co-culture spheroids following eight days
of 3D culture under the conditions indicated. Values denote mean gene expression relative to the mock
control with SEM (n = 2). * p < 0.05; ** p < 0.01; *** p < 0.001.
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2.4. Modified Response of PCa/CAF Co-Culture Spheroids to Anti-Androgens
We next investigated the effect of the anti-androgens bicalutamide and enzalutamide on spheroid
growth. Again we chose a treatment time of 10 days. At this time point, LNCaP cells were significantly
inhibited by 5 µM enzalutamide when grown under 2D culture conditions (Supplementary Materials
Figure S2). Notably, CAFs were not inhibited by the anti-androgens when cultured under 2D
(Supplementary Materials Figure S2) or 3D conditions (Figure 6A). Even higher concentrations of
enzalutamide (50 µM) failed to inhibit CAF 3D spheroids. This is consistent with their very low
expression levels of AR (Supplementary Materials Figure S1). LAPC4 spheroids were significantly
inhibited by enzalutamide (5 µM, p = 0.003) and to a lesser extent also by bicalutamide (5 µM,
p > 0.05). Similar effects were observed in LAPC4/CAF co-culture spheroids. DuCaP spheroids also
responded with significantly reduced cell growth upon treatment with enzalutamide (5 µM, p = 0.028)
but not with bicalutamide (5 µM, p > 0.05). However, DuCaP/CAF spheroids were not inhibited
by the anti-androgens at this concentration. In LNCaP monoculture and LNCaP/CAF co-culture
spheroids 5 µM of bicalutamide or enzalutamide failed to reduce cell viability (Figure 6A), although
this concentration of the anti-androgens inhibited LNCaP 2D monolayer cultures (Supplementary
Materials Figure S2). When the concentration of enzalutamide was increased to 50 µM, however,
cell viability was significantly inhibited in both LNCaP and DuCaP monoculture and LNCaP/CAF
but not in DuCaP/CAF co-culture spheroids (Figure 6B), again suggesting that the impact of CAFs on
anti-androgen response was most pronounced in DuCaP/CAF.
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Figure 6. Effects of anti-androgens on prostate cancer s t . (A) CAF 3D spheroids w re
treat d with 5 or 50 µM enzalutamide over 10 days. PCa on lt r CAF co-culture
spheroids were treated with bicalutamide ( I ) a enzalutamide (ENZ) at a final concentration of
5 µM in standard culture ediu containing 10 FCS. Treat ent as started at day 4 when spheroids
were visible. Cell viability was determined after 10 days of treatment via ST-1 assay and expressed
as mean absorbance; (B) LNCaP, DuCaP monoculture, and LNCaP/CAF, DuCaP/CAF co-culture
spheroids were treated with 5 and 50 µM enzalutamide (ENZ) over 10 days and cell viability was
measured via WST-1 assay. Values denote mean absorbance plus SEM (n = 3). * p < 0.05; ** p < 0.01;
*** p < 0.001.
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One possible explanation for decreased sensitivity to anti-androgens, especially in DuCaP/CAF,
might be elevated AR expression [4]. However, when we compared AR expression levels of 2D and 3D
cultures there were no significant differences in LAPC4 and LNCaP. In DuCaP 3D spheroids, AR levels
were even lower than in 2D monolayer cultures (Figure 7A). Notably, AR protein levels of DuCaP
3D spheroids were similar to those detected in LNCaP 3D spheroids, although in 2D culture, DuCaP
express significantly higher levels of AR than LNCaP cells. CAFs expressed only low to undetectable
levels of AR (Supplementary Materials Figure S1). Thus, the diminished response of spheroids to
anti-androgens is unlikely due to elevated AR levels.
Besides AR signaling, inactivation or loss of phosphatase and tensin homologue (PTEN) with
concomitant activation of Akt resulting in increased cell survival are strongly implicated in PCa
progression [16]. In addition, Akt signaling has been previously associated with the formation of
cell-to-cell junctions coordinated by E-cadherin [17]. We therefore looked further into the activation of
Akt in LNCaP cells under 3D culture since these cells exhibit substantial amounts of pAkt (Figure 7A).
Compared to 2D culture, we found that pAkt levels were increased in LNCaP monoculture and
LNCaP/CAF co-culture spheroids (Figure 7A). In DuCaP and LAPC4 2D cultures, on the other hand,
pAkt levels were low to undetectable and were not increased in 3D spheroids. Treatment with 25 µM of
the PI3K inhibitor LY294002 significantly inhibited the growth of LNCaP and LNCaP/CAF spheroids
(Figure 7B). A combination of LY294002 and 5 µM enzalutamide, however, did not result in additional
growth inhibition compared to LY294002 alone.
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Figure 7. AR and pAkt expression in 3D spheroids compared to 2D monolayer cultures. (A) Expression
of pAkt (Ser457) and androgen receptor (AR) were determined in 3D mono- and co-culture spheroids
of the different cell lines by Western blotting after eight days of culture and compared with that of
the corresponding 2D monolayers. GAPDH was used as normalization control. Representative blots
are shown; (B) Representative fluorescence images showing LNCaP and LNCaP/CAF spheroids after
10 days of treatment with 5 µM enzalutamide (ENZ), 25 µM LY294002 (LY), or a combination of both
(5 µM ENZ and 25 µM LY). CAFs were tracked via GFP (magnification 40×, scale bar: 500 µm); (C) Cell
viability was assessed in LNCaP and LNCaP/CAF spheroids by WST-1 assay after 10 days under the
conditions indicated and expressed as mean absorbance plus SEM. * p < 0.05; ** p < 0.01; *** p < 0.001.
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3. Discussion
In the present study we used co-culture spheroids established from three PCa cell lines grown
together with CAFs to investigate their usefulness as a tissue-mimetic in vitro model for PCa. The PCa
cell lines used (LNCaP, DuCaP, LAPC4) all formed spheroids when grown in scaffold-free 3D hanging
drops that strongly differed in morphology and size. Whereas LNCaP cells formed irregular stellate
forms with moderate gain in size over time, LAPC4 and DuCaP cells produced compact round
spheroids that significantly increased in size over a culture period of eight days. Notably, cell viability
was generally lower in 3D culture compared to 2D monolayers and PCa/CAF co-culture spheroids
were smaller than PCa monoculture spheroids. This is consistent with findings by Sieh et al., who
reported that LNCaP cells grown together with human osteoblasts form smaller colonies on PEG
hydrogels than LNCaP alone [18]. The reduced size of PCa/CAF co-culture spheroids compared with
PCa monoculture spheroids could be explained by the lower cell viability in 3D culture in general.
It is also conceivable that the cells form more compact spheroids due to the direct cell-to-cell contact
of the tumor epithelial cells with the CAFs. An interesting observation was that CAFs formed small
stromal “islands” within the co-culture spheroids, which decreased over time, with less than 10% CAFs
remaining after eight days despite a seeding ratio between PCa cells and CAFs of 1:1. In this regard,
it should be strongly considered that CAFs not only exhibited lower cell viability/metabolic activity
when grown in 3D hanging drops, as assessed by WST-1 assay, but also had a reduced number of
population doublings than CAFs in 2D monolayer culture. This could be simply because of suboptimal
culture conditions for CAFs in the 3D hanging drops or also due to contact inhibition through the
tumor cells. A loss of fibroblasts was also observed in a non-small cell lung cancer (NSCLC) co-cultured
with fibroblasts in hanging drops [19]. In addition, a recent study by Chatterjee and coworkers has
shown that in human PCa tissue the amount of stroma decreases with tumor progression whereas the
tumor epithelial components significantly increase [20]. These data indicate that the PCa cells are the
predominant cell type in human PCa in vivo and displace the stromal cells over time, a phenomenon
that is similar to that observed in our PCa/CAF spheroids. Further studies are required to explore the
reasons underlying the loss of stromal cells in co-culture with PCa cells.
Analysis of PCa and PCa/CAF spheroids upon expression of epithelial and stromal cell type
specific markers revealed a significant increase in E-cadherin protein levels compared to 2D monolayers,
suggesting that the cells strongly upregulate E-cadherin mediated cell-to-cell adhesion when grown in
scaffold-free hanging drops. These results are in line with previous studies that described increased
E-cadherin levels in ovarian cancer cells [14] and primary hepatocytes [21] grown under 3D conditions.
Vimentin protein levels, on the other hand, remained unchanged in PCa 3D spheroids compared to 2D
cultures. Substantial vimentin expression, however, was found in PCa/CAF co-culture spheroids and
most likely originated solely from the CAFs, as demonstrated by separated analysis of PCa cells and
CAFs following cell sorting. The relatively high levels of vimentin protein, especially in DuCaP/CAF
co-culture spheroids, were somehow unexpected due to the low to undetectable mRNA expression
and may be responsible for the strongly diminished anti-androgen response in this cell line compared
to LNCaP and LAPC4.
AR levels were unchanged in LNCaP and LAPC4 3D spheroids, and even decreased in DuCaP
spheroids and in PCa/CAF co-culture spheroids compared to 2D cultures. These changes in AR
expression might also influence androgen responsiveness of the spheroids, which was reduced in
LNCaP/CAF and DuCaP/CAF co-culture spheroids compared to LNCaP and DuCaP monoculture
spheroids. Despite this reduced androgen sensitivity with respect to cell viability, the tumor cells
within the co-culture spheroids still showed induction of androgen-regulated genes such as PSA and
FKBP5 upon androgen stimulation, pointing to an essential role of the CAFs in determining the drug
sensitivity of the tumor cells. Here, it should be considered that CAFs were not androgen responsive,
neither in 2D nor in 3D culture; they lacked AR expression and thus were most likely not direct targets
of androgens or anti-androgens themselves.
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Previous studies have demonstrated that 3D cultured cells are less sensitive to anti-cancer agents
than 2D cultures [22–24]. LNCaP cells, for instance, are more resistant to the chemotherapeutic drug
docetaxel when maintained in polydimethylsiloxane (PDMS) micro-wells than conventionally grown
2D cells [23]. Ewing tumor cells grown in 3D culture also showed profound chemoresistance to a panel
of cytotoxic drugs compared with adherent monolayer cultures [22]. In this study we found that
the CAFs modified the sensitivity of PCa cells to the anti-androgens bicalutamide and enzalutamide;
however, with different impact among the three PCa cell lines. A loss of anti-androgen sensitivity
was most pronounced in DuCaP/CAF cells, where even high concentrations of enzalutamide (50 µM)
failed to exert an inhibitory effect. In LNCaP/CAF, on the other hand, an increase of enzalutamide
from 5 to 50 µM improved the response, whereas LAPC4/CAF still showed a response to enzalutamide
even with low concentrations of 5 µM. Again, it must be considered that CAFs were not inhibited
but even stimulated in growth by enzalutamide, thereby strongly influencing drug response in 3D
co-culture. Increased AR expression has previously been described to promote the development of
CRPC and resistance to the anti-androgen bicalutamide [4]. However, as mentioned above, AR levels
remained unchanged or even decreased in PCa/CAF co-culture spheroids. Another possible reason for
the increased anti-androgen resistance might be impaired access of the drug, particularly to those cells
in the center of the spheroids. Although we did not observe a diminished sensitivity of 3D spheroids
to other exogenously added molecules including R1881 (regulation of androgen target genes PSA and
FKBP5 was very similar to that in 2D cultures), drug uptake studies are warranted to clearly answer
this question.
Because of the strong upregulation of E-cadherin in the 3D spheroids herein, we further looked
into pathways that could be linked to this molecule. PI3K/Akt signaling plays an important role in
PCa development, progression, and treatment resistance [25–28]. Moreover, an increase in E-cadherin
was associated with activation of the PI3K-Akt signaling in 3D cultured Ewing tumor cells [22].
We observed that pAkt levels were strongly increased in PTEN-negative LNCaP spheroids, with even
higher levels upon co-culture with CAFs. Moreover, in contrast to 5 µM enzalutamide, which failed
to inhibit spheroid growth, the PI3K inhibitor LY294002 attenuated LNCaP and even LNCaP/CAF
spheroid growth, suggesting that upregulation of E-cadherin together with elevated activation of
Akt is critical for growth and survival of PTEN-negative PCa spheroids, driving the cells to higher
resistance towards anti-androgens.
In summary, this study shows that CAFs influence the drug response of PCa cells; however,
the impact strongly varies among the different cell lines. We consider PCa/CAF co-culture spheroids
a useful in vitro model with organotypic features that can be used to efficiently investigate drug effects
in a more reliable tissue-mimicking situation.
4. Materials and Methods
4.1. Cell Lines and Reagents
LNCaP PCa epithelial cells, obtained from the American Type Culture Collection (ATCC, Rockville,
MD, USA) and immortalized CAFs—previously established and described by Madar et al. [29]—were
cultured in DMEM (Szabo Scandic, Vienna, Austria) with 10% fetal calf serum (FCS, Gibco BRL,
Life Technologies, Carlsbad, CA, USA), 1% GlutaMAXTM (Gibco), and 1% penicillin and streptomycin
(Lonza, Basel, Switzerland). DuCaP was obtained from Professor J. Schalken (Center for Molecular
Life Science, Nijmegen, The Netherlands) and maintained in RPMI with 10% FCS [30]. LAPC4 were
a gift from Professor A. Cato (Karlsruhe Institute of Technology, Karlsruhe, Germany) and maintained
in RPMI 1640 (Lonza) supplemented with 10% FCS, 1% GlutaMAX™ (Gibco), 1% penicillin and
streptomycin, and 1 nM dihydrotestosterone (DHT, Sigma, St. Louis, MO, USA). Cell lines’ origins and
characteristics have been reviewed recently [13]. CAFs were stably transfected with green fluorescent
protein (pHR-SFFV-eGFP) to differentiate them from tumor epithelial cells in co-culture spheroids
using a GATEWAY-based lentiviral tetracycline-regulated conditional RNAi system as previously
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described [31]. All cells were cultivated at 37 ◦C in a humidified atmosphere with 5% CO2. The number
of population doublings (PDL) was calculated using the formula PDL = log2 (D/D0) [32], with D
representing the cell number at the time of harvesting and D0 at the time of seeding the cells.
4.2. 3D Cell Culture
For PCa epithelial cell or CAF monocultures, cells were seeded into 96-well Perfecta 3D hanging
drop plates (Sigma) at 7500 cells per drop in 40 µL culture medium. For co-cultures, tumor cells and
CAFs were mixed at a ratio of 1:1 (3800 + 3800 cells). Cells were allowed to form spheroids for four
days. Culture media were replenished every 48 h. Spheroid formation and size was monitored and
imaged with a JuLI Smart Fluorescence Cell Imager microscope (NanoEntek, Pleasanton, CA, USA).
The mean radius (R) of the spheroids was determined according to the equation R = (1/2) × (ab)1/2
as previously described [33] using Image J software (Laboratory for Optical and Computational
Instrumentation (LOCI) of the University of Wisconsin-Madison, Wisconsin-Madison, WI, USA).
4.3. Cell Viability Assay
Cell viability was assessed via WST-1 assay (Roche, Basel, Switzerland) according to the
manufacturer’s protocol. 3D spheroids were transferred into a standard 96-well plate (Sarstedt,
Germany) by centrifugation at 1200 rpm for 5 min. Before addition of WST-1 reagent, spheroids as
well as 2D monolayer cultures were dissociated with 50 µL trypsin/EDTA (Lonza) at 37 ◦C for 20 min.
Enzyme activity was stopped with 50 µL trypsin inhibitor (Sigma). Absorbance was measured with
Chameleon 5025 (HVD Life Sciences, Vienna, Austria) at 420–450 nm.
4.4. Real-Time Quantitative PCR (qPCR)
Spheroids (n = 12) were collected into 1.5-mL Eppendorf tubes by floating the wells with 50 µL
PBS, centrifuged at 6000 RCF for 5 min and pellets shock-frozen in liquid nitrogen. Total RNA was
isolated using the RNeasy mini kit (Qiagen, Hilden, Germany). RNA concentration was measured
with the NanoDrop ND-2000c (Thermo Scientific, Waltham, MA, USA). cDNA synthesis and qPCR
were performed as described previously [34]. TaqMan® gene expression assays for quantification of
glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Applied Biosystems, Foster City, CA, USA),
hydroxymethylbilane synthase (HMBS, Hs00609297_m1), vimentin (VIM, Hs00185584_m1), cytokeratin 18
(KRT18, Hs01920599_gH), cytokeratin 5 (KRT5, Hs00361185_m1), E-cadherin (CDH1, Hs01013955_m1)),
CD44 (CD44, Hs01075861_m1), CD49b (ITGA2, Hs00158127_m1), FKBP5 (Hs01561006_m1), and TP63
(Hs00978338_m1) were used. Primer and probe sequences of AR and PSA were as follows: AR
(forward 5′-AGGATGCTCTACTTCGCCCC-3′, reverse 5′-ACTGGCTGTACATCCGGGAC-3′, probe
5′-FAM-TGGTTTTCAATGAGTACCGCATGCACA-TAMRA-3′) PSA (forward 5′-GTCTGCGGC
GGTGTTCTG-3′, reverse 5′-TGCCGACCCAGCAAGATC-3′, probe: 5′-FAM-CACAGCTGCCCACT
GCAT CAGGA-TAMRA-3′). qPCR was carried out with ABI Prism 7500 Fast RT-PCR System
(Applied Biosystems) cycler. Fold change in gene expression was determined using the mathematical
model ratio 2−∆∆Ct [35].
4.5. Cell Lysate Preparation and Western Blotting
3D spheroids (n = 8) were collected by floating the wells with 50 µL PBS. Samples were then
centrifuged at 6000 RCF for 5 min and cell pellets shock-frozen in liquid nitrogen. Whole cell lysates
from 2D and 3D cultures were generated using Tris Glycine SDS sample buffer (Gradipore, Frenchs
Forest, NSW, Australia) by shaking at room temperature for 1 h and further processed via SDS-PAGE
as described previously [36]. The following primary antibodies were used: α-AR (1:250; PG-21,
Millipore, Darmstadt, Germany), α-vimentin (1:500, Dako, Vienna, Austria), α-pAkt (Ser475, 1:1000,
Cell Signaling, Danvers, MA, USA), α-E-cadherin (1:1000, Cell Signaling), α-smooth muscle actin
(SMA, 1:500, Sigma), α-GAPDH (1:50,000; Millipore).
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4.6. Flow Cytometry
GFP-labeled CAF spheroids (n = 12) were collected and digested with trypsin/EDTA as described
above. Cells were re-suspended in PBS with 0.1% FCS and analyzed with a FACSCanto II flow
cytometer and FACS Diva 6.1.2. and FlowJo software version 7.2.5. (BD Biosciences, Schwechat,
Austria). Fixation and permeabilization of the cells was carried out with Fix and Perm® Cell Fixation
and Permeabilization Kit (An der Grub, Vienna, Austria). For cell sorting, co-culture spheroids
(n = 48) were treated as described above and cells separated by fluorescent cell sorting on a FACSAria
(BD Biosciences). Sorted PCa cells were directly harvested in lysis solution RL (innuPREP Micro
RNA Kit, Analytik Jena, Jena, Germany).
4.7. Drug Treatments
To investigate the effects of drugs in 3D culture, treatment was started four days after seeding
when spheroids had formed and was maintained for 10 days unless otherwise stated. To evaluate drug
response in 2D culture, cells were seeded into six-well plates. Treatment started 24 h later when cells
had attached to the plastic surface and maintained for 10 days unless otherwise stated. The medium
was exchanged twice per week. ADT was mimicked by incubating the cells in a medium containing
3% charcoal-stripped FCS (3% CS). For androgen stimulation, the medium containing 3% CS was
supplemented with R1881 as indicated. The anti-androgens bicalutamide (BIC, Astra Zeneca, Wedel,
Germany) and enzalutamide (ENZ, MedChemExpress, Stockholm, Sweden) were added to a final
concentration of 5 µM, unless otherwise stated, and the PI3K inhibitor LY294002 (Calbiochem, Vienna,
Austria) to 25 µM in a standard culture medium.
4.8. Statistical Analysis
Statistical differences were calculated with the Mann–Whitney U test using SPSS (V15.0).
Compared groups are given in the figures and/or figure legends and significances are encoded
as follows: * p < 0.05; ** p < 0.01; *** p < 0.001. Data are presented as mean plus standard error of the
mean (SEM) from three independent experiments unless otherwise stated.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/17/9/1458/s1.
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